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West Nile (WN) encephalitis is an infectious, nonconta-
gious, arthropod-borne viral disease (1). WN virus belongs to
the family Flaviviridae, genus Flavivirus. Mosquito vectors
transmit the virus among bird populations and, incidentally,
to susceptible mammalian species, including humans and
horses. While infected horses may not exhibit clinical
symptoms, fatal neurologic disease sometimes develops. The
emergence of WN virus in the northeast United States in 1999
and 2000 caused concern among horse owners and veterinary
practitioners (2). Animal exposure to WN virus can be
confirmed serologically by using immunoglobulin M (IgM)-
capture enzyme-linked immunosorbent assay (MAC-ELISA)
and plaque reduction virus neutralization (PRNT) assays
(3,4). Detecting WN virus in animal tissues, by isolation in
cell culture or polymerase chain reaction (PCR), confirms
infection. Cell culture isolation of WN virus from equine brain
tissue can be difficult. It is speculated that the virus does not
replicate to high titer in equine brains (Johnson, unpub.
observation). PCR procedures have been developed to detect
the New York strain (NY99) of WN virus (3,5). A traditional
single-stage reverse transcription PCR (RT-PCR) can identify
WN virus in avian tissue and mosquitoes (3)  However, the
single-stage RT-PCR often lacks the sensitivity to identify
WN virus in equine brain (Johnson, unpub. observation). We
developed a RT-nested PCR (RT-nPCR) to rapidly and
accurately detect WN virus in equine brain.
The Study
Selected primers amplified a portion of the E region of the
genome of WN virus NY99, which encodes the envelope
protein (GenBank Accession Number AF196835). This region
was highly conserved among several WN virus isolates
obtained from the United States in 1999, as well as other WN
virus strains of the same lineage (5). The Primer Designer 4
computer software program (Scientific and Educational
Software, Durham, NC) was used to select primers. First-
stage primer sequences, amplifying a 445-bp region, were
1401: 5'-ACCAACTACTGTGGAGTC-3', and 1845: 5'-TTC-
CATCTTCACTCTACACT-3'. Nested primers amplifying a
248-bp region were 1485: 5'-GCCTTCATACACACTAAAG-3'
and 1732: 5'-CCAATGCTATCACAGACT-3'.
Total RNA was extracted from 50-100 mg of tissue by
using Trizol reagent (Life Technologies, Grand Island, NY)
according to the manufacturer’s instructions. All samples
were extracted and tested in duplicate. A WN virus control
was prepared by extracting RNA from a 100-µL volume
containing 10 50% tissue culture infective dose WN stock
virus. Extracted RNA samples were resuspended in 12 µL
RNase-free water and denatured at 70°C for 10 min. Two
microliters of each denatured RNA sample was added to 48 µL
of RT-PCR mixture with the final composition of 10 mM Tris-
HCl (pH 8.3), 50 mM KCl, 2.0 mM MgCl2, 0.8 mM
deoxynucleoside triphospate (dNTP) pool, 25 units M-MLV
RT, 1.25 units RNase inhibitor, 1.25 units AmpliTaq Gold
(Applied Biosystems, Foster City, CA), and 37.5 pmol each of
the two first-stage primers. Similarly, 2.0 µL of RNase-free
water was added to “no-template” controls that were placed
between diagnostic samples. Reaction tubes were incubated
at 45°C for 45 min and 95°C for 11 min, followed by 35 cycles
of 30-sec denaturation at 95°C, 45-sec primer annealing at
55°C, and 60-sec primer extension at 72°C. The final cycle had
similar conditions except for a 5-min primer extension period.
For the nested reaction, 1.5 µL of the first-stage amplification
product was added to a tube containing 48.5 µL of a PCR
mixture with a final composition of 10 mM Tris-HCl (pH 8.3),
50 mM KCl, 2.0 mM MgCl2, 0.8 mM dNTP pool, 1.25 units
AmpliTaq Gold, and 37.5 pmol each of the nested primers.
Reaction tubes were incubated for 11 min at 95°C, followed by
35 cycles of the cycling conditions described for the first stage.
All incubation and amplification procedures were performed
by using a Perkin-Elmer 9600 PCR system (Applied
Biosystems, Foster City, CA). RT-nPCR product was analyzed
by agar gel electrophoresis followed by ethidium bromide
staining and UV visualization. A 248-bp product indicated
WN virus RNA was present in the original sample (Figure 1).
Duplicate samples with discrepant results were retested. No-
template controls were used to detect possible cross-
contamination. PCR products of selected reactions were
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sequenced and compared with the published sequence of the
NY99 strain of WN virus (5, GenBank Accession Number
AF196835).
Sensitivity of the RT-nPCR was determined by
comparing the endpoint dilution of NY99 WN stock virus
detected in Vero cell culture with the endpoint dilution
detected by RT-PCR. Tenfold dilutions of virus were prepared.
Each dilution was tested in duplicate by cell culture and RT-
nPCR. The endpoint dilution in cell culture was 10-4.5/100 µL.
Endpoint dilutions for detection by RT-PCR were 10-2.5/100 µL
after first-stage amplification, and 10-8.0/100 µL after nested
amplification (Figure 2).
Specificity of the RT-nPCR was examined by testing viral
RNA extracted from St. Louis encephalitis virus, a closely
related flavivirus, as well as bovine viral diarrhea virus and
classic swine fever virus, two other Flaviviridae family
members. Eastern equine encephalitis virus and western
equine encephalitis virus, two unrelated North American
arboviruses affecting horses, were also tested. The RT-nPCR
procedure performed on these samples did not result in
observable amplification. Other reference strains of WN virus
were not available for testing.
A total of 128 equine samples were used. Equine brain,
blood, and cerebrospinal fluid (CSF) samples collected from
suspect WN virus-infected horses were submitted to the
National Veterinary Services Laboratories for testing during
the 1999 and 2000 outbreak seasons. Diagnostic samples
from 31 birds were also tested. All equine and avian brain
tissues were tested by RT-nPCR and virus isolation using
Vero and rabbit kidney cell cultures. Specimens derived from
equine blood samples were also tested serologically, by virus
isolation, or both. Five CSF samples from serologically
positive horses were tested by RT-nPCR.
Seventy-three equine brains were tested for WN virus by
RT-nPCR with 13 yielding positive results (Table).
Retrospectively, the first-stage RT-PCR amplification
products from the positive samples were examined by agar gel
electrophoresis and ethidium bromide staining; two produced
a faint band corresponding to the first-stage product of 445 bp
(data not shown). The 13 RT-nPCR-positive horses had
exhibited typical neurologic signs before death, and sera
submitted from all 13 animals were positive for WN virus
antibodies by PRNT or MAC-ELISA. WN virus was isolated in
cell culture from 10 RT-nPCR-positive horses. Attempts to
isolate virus from the remaining three were unsuccessful. The
remaining 60 equine brains were negative for WN virus by
RT-nPCR and isolation. Sera were available from 15 of the 60
RT-nPCR-negative horses; all 15 were negative for WN virus
antibodies. Additional equine samples tested by RT-nPCR
were plasma (35 samples), serum (10 samples), buffy coat (5
samples), and CSF (5 samples). Several of these samples were
from serologically positive animals; however, all RT-nPCR
tests on these samples were negative. Plasma samples were
obtained from two ponies experimentally challenged with WN
virus; RT-nPCR detected WN virus in plasma from 3 to 7 days
postinoculation (dpi) in one pony and 3-6 dpi in the second
pony (Table). Virus was isolated from the plasma of one pony
at 6 dpi. The ponies were not exhibiting clinical symptoms.
Thirty-one avian brain samples were also tested. Seven of
these samples were positive for WN virus by RT-nPCR and
virus isolation (Table). The remaining 24 samples were
negative by both procedures. Positive RT-nPCR results were
also obtained from tissues (e.g., kidney, spleen, and liver)
from some positive birds (Figure 1, lane 2).
RT-nPCR amplification products from 6 positive samples
collected in 1999 (3 equine, 3 avian) and 12 positive samples
Figure 1. Visualization of reverse transcription-nested polymerase
chain reaction product. West Nile virus-positive samples are
indicated by a 248-bp band. Lane 1: positive crow brain, NY, 1999.
Lane 2: positive crow kidney, NY, 1999. Lane 3: positive Sandhill
Crane brain, CT, 1999. Lane 4: negative crow brain. Lane 5-6:
positive crow brains, NY, 2000. Lane 7: normal control. Lane 8-10:
positive horse brains, NY, 1999. Lane 11: negative horse brain. Lane
12: positive horse brain, RI, 2000. Lane 13: positive horse brain, NJ,
2000. Lane 14: positive horse brain, MA, 2000. Lane 15: positive
horse brain, CT, 2000. Lane 16: normal control. Lane 17: NY99 West
Nile virus control. L: 100-bp DNA ladder. Band artifacts in lanes 1, 3,
5, and 6 are due to large amount of virus present in those samples.
Figure 2. Visual comparison of first stage reverse transcription-
polymerase chain reaction (RT-PCR) amplification products with RT-
nested (n) PCR amplification products. Lanes 1-9 represent first-
stage products of 10-fold dilutions 10-1 through 10-9. Lanes 10-18
represent nested amplification products of same dilutions. L: 100-bp
DNA ladder.
Table. Virus isolation compared with plaque reduction virus
neutralization, immunoglobulin M-capture enzyme-linked immunosor-
bent assay serologic results, or both for West Nile virus samples positive
by reverse transcription-nested polymerase chain reaction
RT-nPCR Results
positive   No.    VI     VI   Sero-  Sero-
samples tested positive negative positive negative
Equine brain 13 10 3 13 0
Equine plasma   8a   1 7   0 8b
Avian brain   7   7 0 NAc NA
RT-nPCR = reverse transcription-nested polymerase chain reaction; VI = virus
isolation; NA = not applicable.
aMultiple plasma samples collected from two experimentally challenged ponies
were RT-nPCR-positive for West Nile virus between 3 and 7 days after
inoculation.
bWest Nile virus antibodies were not detected in either pony until beyond the
time the virus was detected by RT-nPCR.
cNo avian serum was available for testing.741 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
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from 2000 (10 equine and 2 avian) were sequenced and
compared with the published NY99 WN virus sequence (5).
Within the 248-bp amplified region, two horse samples, one
each from 1999 and 2000, had one base change; the remaining
16 samples were identical to NY99 WN virus.
Conclusions
The RT-nPCR proved to be a rapid and reliable method
for detecting WN virus in equine as well as avian tissues.
While isolation of WN virus from the 10 equine isolates
required up to two passages in cell culture and 7-14 days to
complete, WN virus was confirmed in tissue by RT-nPCR in
<24 hours.
End-point dilution tests determined the RT-nPCR
procedure to be 1,000-fold more sensitive than cell culture for
detecting WN virus. Additionally, nested amplification
increased the sensitivity of the RT-PCR at least 100,000-fold
over first-stage amplifiction (Figure 2). Comparison of virus
isolation and RT-nPCR results further demonstrated the
increased sensitivity of RT-nPCR. All RT-nPCR-positive
brain samples were confirmed by virus isolation except three
equine brain tissues; WN virus infection in those animals was
confirmed serologically. Had the procedure consisted of only
first-stage amplification, only two of the positive horses would
have been correctly identified.
Specificity of the RT-nPCR test was confirmed by
sequence analysis of the amplified products of 18 positive
samples and by absence of amplification of St. Louis
encephalitis, bovine viral diarrhea, classic swine fever,
eastern equine encephalitis, and western equine encephalitis
viruses. Complete agreement between negative RT-nPCR
tests on brain tissues and all other WN virus diagnostic tests
performed further demonstrates the specificity of the assay in
identifying animals not infected with WN virus.
Equine blood-derived samples and CSF samples from
clinically ill animals were not reliable for determining the
presence of WN virus by either RT-nPCR or isolation. Limited
information from two experimentally challenged ponies
indicated a several-day viremic phase early after infection,
before WN virus antibody was detectable. Taken together, our
data suggest that the viremic phase of infection occurs before
clinical symptoms develop. Therefore, the RT-nPCR would
not be expected to detect WN virus in blood of horses
exhibiting clinical signs of WN virus encephalitis.
Additionally, while WN virus-specific IgM antibodies may be
detected in equine CSF during clinical illness, CSF samples
do not appear to have diagnostic value for detecting WN virus
RNA in horses.
As with all nested PCR procedures, additional
manipulation of reaction tubes can lead to cross-
contamination, corrupting the test (6). Confidence in the
procedure may be increased by testing duplicate samples and
including multiple controls.
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